These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 20435238

  • 1. Three-week combination treatment with ACTH + magnesium sulfate versus ACTH monotherapy for infantile spasms: a 24-week, randomized, open-label, follow-up study in China.
    Zou LP, Wang X, Dong CH, Chen CH, Zhao W, Zhao RY.
    Clin Ther; 2010 Apr; 32(4):692-700. PubMed ID: 20435238
    [Abstract] [Full Text] [Related]

  • 2. [A comparative study of conventional dose and low dose adrenocorticotrophic hormone therapy for West syndrome].
    Shu XM, Li J, Zhang GP, Mao Q.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):445-8. PubMed ID: 19558807
    [Abstract] [Full Text] [Related]

  • 3. Extremely low-dose ACTH step-up protocol for West syndrome: maximum therapeutic effect with minimal side effects.
    Oguni H, Yanagaki S, Hayashi K, Imai K, Funatsuka M, Kishi T, Osawa M.
    Brain Dev; 2006 Jan; 28(1):8-13. PubMed ID: 15925463
    [Abstract] [Full Text] [Related]

  • 4. Major adverse events associated with treatment of infantile spasms.
    Partikian A, Mitchell WG.
    J Child Neurol; 2007 Dec; 22(12):1360-6. PubMed ID: 18174552
    [Abstract] [Full Text] [Related]

  • 5. Infantile spasms and cytomegalovirus infection: antiviral and antiepileptic treatment.
    Dunin-Wasowicz D, Kasprzyk-Obara J, Jurkiewicz E, Kapusta M, Milewska-Bobula B.
    Dev Med Child Neurol; 2007 Sep; 49(9):684-92. PubMed ID: 17718825
    [Abstract] [Full Text] [Related]

  • 6. Zonisamide in West syndrome: an open label study.
    Yum MS, Ko TS.
    Epileptic Disord; 2009 Dec; 11(4):339-44. PubMed ID: 20045779
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of West syndrome].
    Cvitanović-Sojat L, Gjergja R, Sabol Z, Hajnzić TF, Sojat T.
    Acta Med Croatica; 2005 Dec; 59(1):19-29. PubMed ID: 15813352
    [Abstract] [Full Text] [Related]

  • 8. Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: a randomized, open-label, crossover study in Taiwan.
    Tsai YS, Lan SK, Ou JH, Tzai TS.
    Clin Ther; 2007 Apr; 29(4):670-82. PubMed ID: 17617290
    [Abstract] [Full Text] [Related]

  • 9. A case-control evaluation of the ketogenic diet versus ACTH for new-onset infantile spasms.
    Kossoff EH, Hedderick EF, Turner Z, Freeman JM.
    Epilepsia; 2008 Sep; 49(9):1504-9. PubMed ID: 18410363
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 11. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

  • 12. Long-term (120-Week) antiviral efficacy and tolerability of fosamprenavir/ritonavir once daily in therapy-naive patients with HIV-1 infection: an uncontrolled, open-label, single-arm follow-on study.
    Gathe JC, Wood R, Sanne I, DeJesus E, Schürmann D, Gladysz A, Garris C, Givens N, Elston R, Yeo J.
    Clin Ther; 2006 May; 28(5):745-54. PubMed ID: 16861096
    [Abstract] [Full Text] [Related]

  • 13. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 14. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [Abstract] [Full Text] [Related]

  • 15. Hypothalamic hamartoma and infantile spasms.
    Kerrigan JF, Ng YT, Prenger E, Krishnamoorthy KS, Wang NC, Rekate HL.
    Epilepsia; 2007 Jan; 48(1):89-95. PubMed ID: 17241213
    [Abstract] [Full Text] [Related]

  • 16. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
    Gleim GW, Rubino J, Zhang H, Shahinfar S, Soffer BA, Lyle PA, Littlejohn TW, Feig PU.
    Clin Ther; 2006 Oct; 28(10):1639-48. PubMed ID: 17157119
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 18. Adrenocorticotropic hormone for the treatment of West Syndrome in children.
    Shumiloff NA, Lam WM, Manasco KB.
    Ann Pharmacother; 2013 May; 47(5):744-54. PubMed ID: 23606552
    [Abstract] [Full Text] [Related]

  • 19. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T, White D, Schmidt-Nowara W, Wesnes KA, Niebler G, Arora S, Black J.
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH, Stein EA, Bays HE, Maki KC, Doyle RT, Shalwitz RA, Ballantyne CM, Ginsberg HN, COMBination of prescription Omega-3 with Simvastatin (COMBOS) Investigators.
    Clin Ther; 2007 Jul; 29(7):1354-67. PubMed ID: 17825687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.